Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer

Large investments by pharmaceutical companies in the development of new antineoplastic drugs have not been resulting in adequate advances of new therapies. Despite the introduction of new methods, technologies, translational medicine and bioinformatics, the usage of collected knowledge is unsatisfactory. In this paper, using examples of pancreatic ductal adenocarcinoma (PaC) and castrate-resistant prostate cancer (CRPC), we proposed a concept showing that, in order to improve applicability of current knowledge in oncology, the re-clustering of clinical and scientific data is crucial. Such an approach, based on systems oncology, would include bridging of data on biomarkers and pathways between different cancer types. Proposed concept would introduce a new matrix, which enables combining of already approved therapies between cancer types. Paper provides a (a) detailed analysis of similarities in mechanisms of etiology and progression between PaC and CRPC, (b) diabetes as common hallmark of both cancer types and (c) knowledge gaps and directions of future investigations. Proposed horizontal and vertical matrix in cancer profiling has potency to improve current antineoplastic therapy efficacy. Systems biology map using Systems Biology Graphical Notation Language is used for summarizing complex interactions and similarities of mechanisms in biology of PaC and CRPC. © 2018, Arányi Lajos Foundation.

Authors
Fucic A.1 , Aghajanyan A. 2 , Culig Z.3 , Le Novere N.
Publisher
Kluwer Academic Publishers
Language
English
Status
Published
Year
2018
Organizations
  • 1 Institute for Medical Research and Occupational Health, Ksaverska c 2, Zagreb, 10000, Croatia
  • 2 Institute of Medicine, Peoples’ Friendship University of Russia, Moscow, Russian Federation
  • 3 Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
  • 4 Babraham Institute, Cambridge, United Kingdom
Keywords
Cancer marker; Cancer profiling; Castrate resistant prostate cancer; Pancreatic cancer; Systems oncology
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/7139/
Share

Other records